Product news

Share this article:
FDA has approved an NDA for LoSeasonique, an oral contraceptive manufactured by Duramed, a subsidiary of Barr Pharmaceuticals.
 
Eli Lilly & Co. has announced the introduction of a color differentiation system for U-100 insulin products marketed in the US, including vials, pens and individual packaging for Humalog and Humulin
Share this article:
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.